Prostate cancer testing has received significant attention lately as the industry seeks to find reliable ways of identifying the appropriate treatment strategy for patients diagnosed with such cancer. A new draft local coverage determination (LCD) proposed by Medicare Administrative Contractor Palmetto GBA notes that “[i]n 2014, nearly 233,000 men in the US will be diagnosed…
Palmetto GBA Issues Proposed Draft LCD for Oncotype DX® Prostate Cancer Assay
by Glenn S. Demby | Jun 3, 2015 | National Lab Reporter | 0 comments